Precision medicine and data
Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: June 5, 2026
Back to directorynference nSights medical AI product profile
Multimodal real-world evidence platform that applies human and AI intelligence to longitudinal EHR and other clinical data.
Precision medicine and data
Best fit
Research teams exploring patient cohorts, multimodal data signals, drug or diagnostic development questions, and code-free RWE workflows.
- Primary use case
- AI-assisted multimodal real-world data exploration, cohort analysis, clinical research insights, drug development support, and predictive model development
- Audience
- Clinical researchers, drug developers, diagnostics teams, data science groups, and real-world evidence teams
- Risk level
- High
- Pricing signal
- Enterprise data and analytics access pricing; request current product, dataset, and licensing terms.
- Official sources
- 4 official sources
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating nference nSights as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as research and evidence infrastructure unless outputs are linked to patient-specific care, diagnostics, or regulated submissions that require formal controls. |
|---|---|
| Privacy | Review de-identification, federated or licensed-data access, institution data rights, modality add-ons, exports, retention, and user permissions before using sensitive cohorts. |
| Evidence | Validate cohort logic, source-data completeness, AI curation methods, modality coverage, missingness, and reproducibility for the intended drug, diagnostic, or research question. |
| Workflow | Best used with clinical research, informatics, biostatistics, privacy, and domain-science review before insights feed experiments, publications, models, or development programs. |
Where nference nSights fits
nference describes nSights as a suite of multimodal AI applications using longitudinal EHR and real-world data to support clinical research, drug development, diagnostics, RWE generation, and predictive model development.
Not for: Direct patient diagnosis, treatment selection, or clinical operations changes without protocol, privacy, statistical, and domain review.
What to verify before using nference nSights
- Which nSights application, dataset, modality, institution source, or analytics tier is available for the research question.
- Data provenance, de-identification, cohort representativeness, refresh cadence, modality completeness, and whether requested variables are reliably captured.
- How AI-curated data, code-free analyses, cohort outputs, and predictive-model inputs can be traced, reproduced, and externally validated.
- Whether the project needs IRB review, data-use approval, biostatistical review, model governance, or regulatory submission controls.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- nference.com / nsights
- nference.com / data-modality
- nference.com / publications
- nference.com / privacy-policy
Related medical AI products
Precision medicine and data
Anumana ECG-AI
Cardiovascular AI platform using standard 12-lead ECGs to surface signals such as low ejection fraction, pulmonary hypertension, and cardiac amyloidosis for clinician follow-up.
Precision medicine and data
Eko Health SENSORA
FDA-cleared cardiovascular detection platform that pairs Eko digital stethoscopes with AI-supported ECG and heart-sound analysis for supervised point-of-care screening.
Precision medicine and data
AliveCor Kardia 12L
Portable AI-powered 12-lead ECG system that uses a reduced leadset and KAI 12L algorithms to support clinician-reviewed cardiac determinations.